Denali Therapeutics (DNLI) Tax Provisions (2019 - 2023)
Denali Therapeutics (DNLI) reported Tax Provisions of $30000.0 for Q4 2023, up 600.0% year-over-year from $4285.7 in Q4 2022, and up 600.0% quarter-over-quarter from -$6000.0 in Q4 2022.
Denali Therapeutics (DNLI) Tax Provisions (2019 - 2023) Analysis & Trends
Denali Therapeutics (DNLI) has 5 years of Tax Provisions data on file, last reported at $30000.0 in Q4 2023.
- Tax Provisions for Q4 2023 came in at $30000.0, up 600.0% year-over-year; the trailing twelve-month figure through Dec 2023 was $24000.0 (up 104.33% YoY), and the FY2025 annual result was $102000.0, up 50.0% from the prior year.
- Tax Provisions climbed to $30000.0 in Q4 2023 per DNLI's latest filing, from -$6000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $823000.0 in Q4 2020 and troughed at -$575000.0 in Q4 2021.
- A 5-year average of -$12700.0 and a median of $10500.0 in 2022 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2021 and 2023: Tax Provisions plunged 169.87% in 2021, then jumped 600.0% in 2023.
- A 5-year view of Tax Provisions shows it stood at -$113000.0 in 2019, then surged by 828.32% to $823000.0 in 2020, then sank by 169.87% to -$575000.0 in 2021, then surged by 98.96% to -$6000.0 in 2022, then jumped by 600.0% to $30000.0 in 2023.
- Business Quant data shows DNLI's Tax Provisions at $30000.0 in Q4 2023, -$6000.0 in Q4 2022, and $27000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Denali Therapeutics | 4.35 Bn | 4.35 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 30,000.00 |
| Dec 31, 2022 | -6,000.00 |
| Jun 30, 2022 | 27,000.00 |
| Dec 31, 2021 | -575,000.00 |
| Dec 31, 2020 | 823,000.00 |
| Sep 30, 2020 | 56,000.00 |
| Jun 30, 2020 | 79,000.00 |
| Mar 31, 2020 | -135,000.00 |
| Sep 30, 2019 | -113,000.00 |
| Jun 30, 2019 | -313,000.00 |